Collection of population data on capillary blood levels of different antihypertensive agents in kidney transplant recipients with immunosuppressive treatment.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028915

Enrollment

200

Registered

2022-05-02

Start date

2021-10-19

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension in Kidney Transplant Recipients

Interventions

Group 1: 20 µl of capillary blood are sampled from kidney transplant recipients under immunosuppressive and antihypertensive treatment.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - age = 18 years - kidney transplant recipient - medical treatment of hypertension with mono or combination drugs containing agents bisoprolol, ramipril, candesartan, valsartan and/or hydrochlorothiazide

Exclusion criteria

Exclusion criteria: - acute infections like hepatitis B or C, HIV et. al. - participation only with signed informed consent

Design outcomes

Primary

Measure	Time frame
Identification of the influence of polymedication on blood levels of different antihypertensive agents.	—

Secondary

Measure	Time frame
Collection of data on adherence of patients via dried blood spot technique.	—

Countries

Germany

Contacts

Public ContactChristoph Wanner

Universitätsklinikum WürzburgMedizinische Klinik und Poliklinik IAbteilung Nephrologie

Wanner_C@ukw.de+49 931 201 39030

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026